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In this paper, we carry out an examination of four mechanisms that can potentially lead
to changing morphologies in a growing tumor: variations in nutrient consumption rates,
cellular adhesion, excessive consumption of nutrients by tumor cells and immune cell
interactions with the tumor. We present numerical simulations using a hybrid PDE-cellular
automata (CA) model demonstrating the effects of each mechanism before discussing
hypotheses about the contribution of each mechanism to morphology change.
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1. Introduction
Over the past three to four decades, tumor growth and the dynamics of the immune system
have been a significant focus for both experimentalists and mathematical modelers.
Mathematical modeling in this area stems from the early chemical diffusion and differential
equation models of Burton [11] and Greenspan [31] and has grown into an extensive field of
literature with studies presented using partial and ordinary differential equations (PDEs and
ODEs) (see for example [12,13,41,46,54]), cellular automata (CA) (see for example
[2,7,26,36,43,49]) and many statistically based studies. An excellent review of mathematical
models of tumor growth and some of the closely related literature was recently given by
Araujo and McElwain [5].
The mathematical modeling of the immune system in its various roles is also a rich field of
study. For example, Perelson provides a substantial review of the immune system before
demonstrating the process of modeling the immune system from the point of view of a
physicist [52]. Ordinary differential equations are widely used to model the kinetics of the
immune response as illustrated in the work of Merrill [45], Callewaert et al. [14], and
Perelson and Macken [51]. CA methods have also arisen in immune system modeling such as
in the “IMMSIM” model of Seiden and Celada [59].
Bellomo and Maini [8] note that a significant issue in the modeling of biological systems is
the multiscale nature of many such systems. They discuss three distinct but linked levels: the
sub-cellular level which covers gene expression, receptor binding and cellular signaling; the
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cellular level where, for example, cellular interactions regulated by sub-cellular signals are
considered; and the macroscopic level. The cellular level of biological systems is often
modeled using nonlinear integro-differential equations or by discrete, agent-based models
[50,53,57]. In relation to the cellular level of tumor growth, when cell proliferation is not
suppressed by the immune system, tumor cells may condense to form a solid mass, leading
researchers to develop an interest in descriptions of tumor growth at the macroscopic scale,
[9]. At this macroscopic level we can study interactions between the host and macroscopic
boundaries, such as tumor boundaries, or the behavior of aggregate cell populations which
might lead to tissue heterogeneity. Such systems can be investigated using moving boundary,
nonlinear partial differential equation systems, via level-set methods, or using mean-field
models, [16,17,19]. Greller et al. [32] provide a generalized conceptual foundation for the
modeling of tumor growth and heterogeneity produced therein.
The model developed here couples the growth of a tumor mass with the response of the
immune system. We use partial differential equations to provide a macroscopic description of
relevant nutrients, combined with a discrete strategy which considers the behavior of
individual cells and their interactions, at the cellular level. Thus, the model can be considered
a hybrid of the macroscopic approach and an agent-based approach. Greller et al. [32] offer
astute reasons for taking care when taking the continuum limit of a microscopic process. In
this case, the validity of a continuum model of the molecular concentrations has been justified
historically by the use of the continuous diffusion equation to model the diffusion of small
molecules through tissue, e.g. [23,24,65]. Furthermore, the timescale of molecular diffusion is
short relative to that of tumor cell growth, justifying the modeling of the small molecule
population as an aggregate. Tumor–immune cell interactions on the other hand, are modeled
at the cellular level: since we are interested here in explaining tumor morphologies and
specific immune cell recruitment, the explicit modeling of the movements and interactions of
individual cells is important. Therefore, rules of evolution based on the state and location of
individual cells are derived and implemented, (see section 2).
A number of previous mathematical models have also coupled tumor growth with
immune system dynamics. The majority of the coupled models are fully deterministic and
are comprised of a series of ODEs or PDEs describing the dynamics of, for example, tumor
cells, host cells and immune cells [6,19,21,28,37,39,40,44,46–48,62]. Bellouquid and
Delitala [9] model the dynamics of general populations of interacting cells using kinetic
theory and non-equilibrium statistical mechanics before offering specific examples.
Coupled tumor-immune system models, both cellular and sub-cellular level depictions, are
reviewed by Adam and Bellomo [1] and discussed again later in [55]. In more recent works,
immunotherapy has also been investigated using similar ODE models coupled with optimal
control theory [10,20,22].
Most of these tumor-immune system models are fully deterministic, and while some
models consider spatial tumor–immune interactions, these often focus on very simple spatial
domains [44,46,48]. Here we also model temporal evolutions but extend the spatial
consideration to a two-dimensional domain employing a hybrid CA–partial differential
equation modeling approach.
This deterministic-stochastic CA modeling approach has been successfully used in the past
to model tumor growth, chemotherapeutic treatment and the effects of vascularization on
tumor growth [2,26,27,49]. Here we use reaction-diffusion PDEs to describe chemical
species such as growth nutrients, and a CA strategy to track the tumor cells as well as immune
cell species. Together, these elements simulate the growth of the tumor and the interactions of
the immune cells with the tumor-growth.
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The flexibility of this CA modeling strategy and its computational implementation are
illustrated (and essential) here where we consider a number of different possible causes for
tumor morphology changes.
Similar discrete models, for example the PDE inspired models of Anderson and Chaplain
[4] and off-lattice approach of Drasdo and Loeffler [25], have been used in the study of tumor
growth and related processes. The model in this paper uses phenomenologically sourced,
probabilistic CA rules rather than behaviors taken directly from PDE approximations and is
more structured spatially than the off lattice models.
Using the hybrid CA–PDE model, we consider four mechanisms:
i) nutrient consumption variations,
ii) cell–cell adhesion,
iii) tumor “gluttony” with regard to nutrients, and
iv) immune cell interactions
leading to different morphological structures for two-dimensional tumors. This is
accomplished through the development of a model with cellular behaviors related to those
described in the experimental literature and by considering the ODE models of tumor-
immune system interactions developed in other works (such as [20,22,39]).
In section 2, we present the development of the mathematical model used in this study
including a description of the CA rules. In section 3, representative simulations are presented
in order to gauge the effects of the various mechanisms on the growth of tumors before a
discussion and interpretation of the results is presented in section 4.
2. Model overview
The model we implement is an extension of the CA hybrid model of Mallet and de Pillis [43].
The cell types and chemical species modeled are equivalent, with the exception that the
current model additionally tracks necrotic tumor cells. This work also includes several new
CA rules, other modified or enhanced rules and a number of new assumptions to allow for the
modeling of the different mechanisms responsible for tumor morphology changes.
The nutrient species and cell populations we track with this model are outlined in table 1.
As in [59], we assume the presence of two nutrient types, one necessary for mitosis, and one
necessary for survival. The sections that follow outline the model implemented in this
research.
Table 1. Nutrients and cell types in model.
Variable Description
N(x, y, t) Mitosis nutrient concentration
M(x, y, t) Survival nutrient concentration
H(x, y, t) Normal host cell number
T(x, y, t) Live tumor cell number
Tnec(x, y, t) Necrotic tumor cell number
NK(x, y, t) Total NK immune cell number
L(x, y, t) Total CTL immune cell number
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2.1 Nutrient diffusion
The following assumptions have been made in order to model the evolution of nutrients over
time and in space.
. Both nutrient species are governed by reaction-diffusion equations of the same form, and
diffusion rates for the two nutrients are equal.
. Normal tissue and immune cells consume both nutrients at the same rate a 2
(time21cell21).
. The consumption rate of both nutrients by tumor cells is a constant multiple of the normal
and immune cell consumption rates. These factors are denoted by lM and lN.
. Nutrients diffuse from a blood vessel on the boundary of the computational domain.
Nutrient concentrations at the outer blood vessel wall are assumed to be constant.
The diffusion of the nutrients through tissue is modeled by the following non-
dimensionalized reaction-diffusion equations, as given in [43]:
›N
›t
¼ 72N 2 a2ðH þ NK þ LÞN 2 lNa2TN; ð1Þ
›M
›t
¼ 72M 2 a2ðH þ NK þ LÞM 2 lMa2TM: ð2Þ
The derivation of the non-dimensionalized equations and the justifications for the
parameter choices and simplifications can be found in [43].
2.2 Cell dynamics
As mentioned in the introduction, while we model the diffusion of the nutrients with a system
of reaction-diffusion equations, we model the action of the cell populations using local rules
that are both probabilistic and deterministic. Cells will die, proliferate, or move depending on
both the local concentration of nutrients near the cell and the states of neighboring
cell populations. The parameters implemented for this portion of the model are outlined in
table 2.
2.2.1 Tumor cells. In this model, tumor cells are allowed to divide, move, or die, depending
upon nutrient levels, the presence of immune cells, and forces due to cell–cell adhesion.
Tumor cells die in one of two ways: either they are killed by cytotoxic lymphocytes, or they
die due to insufficient nutrient; in this model, as in [43], cells do not undergo apoptosis. Each
of these changes of state is governed by a probabilistic rule, which can be a function of
nutrient concentrations, M and N, as well as immune cell populations, NK and L.
Of the six probability functions summarized in this section, PL, PLD and PNK have the same
forms and functions as those in [43]. However, Pdel, Pdiv and Pimdth play the same roles but
have different forms. For completeness, therefore, we provide the formulas for all of the
probability functions. To give an idea of the shape of each probability function, sample plots
are provided in figure 1.
Tumor cell death due to insufficient nutrient. Tumor cell populations are updated at each
proliferation time-step by considering each grid element containing a tumor cell in turn,
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using a random ordering of elements at each cell-cycle. Within each grid element, all tumor
cells can potentially change states. First, each tumor cell dies with probability Pdel (see figure
1), a function of the local concentration of the “survival” nutrient, M:
Pdel ¼ exp 2HðM 2MminÞ M 2Mmin
udel
 2" #
; ð3Þ
where H represents the Heaviside step function:
HðxÞ ¼
0 if x , 0;
1 if x $ 0:
(
ð4Þ
The use of the Heaviside function in Pdel forces death of the tumor cell if nutrient
concentration M is below the death threshold, Mmin. Dead cells become part of the necrotic
population, and are removed from the living tumor population.
Tumor cell division due to sufficient nutrient. Next, those tumor cells that do not
undergo necrosis are eligible to divide: each living tumor cell produces a daughter cell
with probability Pdiv (figure 1), a function of the local concentration of the “mitosis”
nutrient, N:
Pdiv ¼ 12 exp 2HðN 2 NminÞ N 2 Nmin
udiv
 2" #
; ð5Þ
Table 2. Description of model parameters used in the hybrid model. Entries marked with a (*) are new additions to
the model, or significantly modified, while all other entries are also components of the model presented in [43].
Parameter Description
lN Multiplier for cancer cell consumption of mitosis nutrient N (cancer consumption rate of
N ¼ lN £ normal cell consumption rate of N)
lM Multiplier for cancer cell consumption of survival nutrient M (cancer consumption rate of
M ¼ lM £ normal cell consumption rate of M)
udiv Parameter inversely related to probability of tumor cell division: increasing udiv decreases
chance of division
Nmin (*) Tumor cell division threshold: if nutrient concentration is less than Nmin, probability
of tumor cell division is 0
udel Parameter affecting probability of cell death: increasing udel increases chance of tumor
cell death
Mmin (*) Tumor cell death threshold: if nutrient concentration is less than Mmin, probability of
tumor cell death is 1
I0 Background ratio of natural killer cells: (Initial # NK cells) /(Total # Grid Elements)
uL Parameter inversely related to CTL induction: increasing uL decreases chance
of induction of CTLs by tumor cells
uLD Parameter for CTL death probability curve: increasing uLD increases chance of CTL death
uN (*) Probability of CTL induction by NK cells: increasing uN increases chance of
induction of CTLs signaled by NK–tumor interactions
Copt (*) The optimal (energy minimizing) number of tumor cells in a grid site
Is (*) Overall immune strength against tumor cells: the smaller the parameter, the higher
the number of immune cells required in the neighborhood of a tumor
cell to kill that cell
CTLkill Number of times one CTL can attack tumor cells before deactivation
NKkill Number of times one NK cell can attack a tumor cell before deactivation
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whereH is the Heaviside step function (see equation (4)). Cell division is only possible if the
concentration of nutrient is above the threshold Nmin, after which the higher the concentration
of nutrient N, the higher the likelihood of cell division.
Tumor cell death due to immune cells. After cell division, living tumor cells are distributed
among the elements in a 3 £ 3 neighborhood of the grid element according to an energy
minimizing adhesion rule, described below. As in [43], Pimdth, the probability that a tumor
cell will be lysed by either the NK cells or the CTLs, is given by
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Figure 1. Plots of probability curves: Top: Pdel Pdiv. Center: Pimdth, PL. Bottom: PLD, PNK.
L. G. de Pillis et al.164
Pimdth ¼ 12 exp½2ðIcntIsÞ2: ð6Þ
Here Icnt is the total number of immune cells, both NK cells and CTLs, in the neighborhood
of the relevant tumor cell: Icnt ¼
P
nbhdðNK þ LÞ. We consider this local neighborhood to
include the eight grid elements surrounding the grid site of interest, but further experimental
information could result in modifications of the definition of this neighborhood.
The rules for immune cell kill of tumor cells are further described in section 2, in which the
evolution of the immune cell populations is discussed.
Modeling cell–cell adhesion and invasion. This model attempts to capture the behavior of
proliferating tumor cells as they become crowded and invade neighboring grid elements. It is
important to consider the effects of cellular adhesion between cells and the extra-cellular
matrix (ECM) since the secretion or suppression of adhesion molecules is a possible
mechanism for the onset of metastasis [3,29,33]. Mathematical models incorporating
adhesion include [12,42,56], while [17,60] explore the relationship between cell–cell
adhesion, tumor morphology, hypoxia and disease prognosis.
Turner [63,64], provides a method for estimating the diffusion coefficient for biological
cells modeled as adhesive, deformable spheres by considering the “potential energy of
interaction” between individual cells. Turner shows that the diffusion coefficient is
proportional to the second derivative of the grid element’s potential energy function,
E(T),which can be derived in terms of the biological parameters of individual cells, such as
elasticity and adhesiveness, (see figure 2). In this model we adapt Turner’s method to the CA
framework by redistributing living tumor cells after each proliferation step according to the
following rule. The energy function is parametrized by its minimizing value, denoted by
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Figure 2. Potential energy function, E(T).
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Copt. If a newly updated grid element contains more than Copt cells, excess cells are
distributed in the element’s 3 £ 3 neighborhood by moving cells to any element with fewer
than Copt cells, in order of decreasing cell density. This way, elements with cell populations
closest to Copt are filled up to Copt first. If, after this initial redistribution, the center grid
element still contains more than Copt cells, living cells are evenly distributed, one by one, in a
random order, to neighboring grid elements. The center grid element is not allowed to
contain more than Copt cells. This provides a mechanism for inducing metastasis; for
example, by setting Copt to zero, living tumor cells are forced to metastasize.
2.2.2 Immune cells. NK cells are part of the innate immune response, and in this model are
present at all times. They are allowed to roam freely and randomly through the computational
grid, taking action when they do encounter a tumor cell. As in [43], in order to maintain the
background immune system level, we impose a rule to generate new immune cells.
NK cell production. The homeostatic level of natural killer (NK) cells is determined by a
fixed parameter of the system, denoted by
I0 ¼ Initial # NK cells
Total # Grid elements
:
At each cell-cycle, new NK cells are generated in any grid element without an NK cell in it
with probability PNK (see figure 1).
The probability that a new NK cell will be produced is given by
PNK ¼ I0 2 Current # NK Cells
Total # Grid Elements
: ð7Þ
PNK is the difference of the a priori specified background ratio of NK cells to normal cells
and the current NK to normal cell ratio. The likelihood of generating a new NK cell goes
down as the total NK cell count goes up.
CTL induction. Unlike NK cells, CTLs are specific killers, and so they must be primed and
recruited to the region of the tumor through various signals. To reduce computational
requirements, we assume that NK cells and CTL cells do not occupy the same grid site at the
same time. This then implies that a tumor cell is either killed by NK cells or by CTLs, but not
by both simultaneously. This simplifying assumption is not a major hindrance to the
functioning of the overall immune response to the tumor, but it is one that we wish to modify
in future versions of this model.
The rules for the induction of CTLs in this model are as follows: if at least one tumor cell
and one NK cell share the same grid site, then, with probability uN we induce the recruitment
of CTLs to that location. Thus, the larger uN, the greater the chance of recruiting CTLs to a
location that presumably contains tumor cell detritus.
Similarly, if a tumor cell and CTLs share a location, more CTLs will be recruited to that
spot, with a probability, PL (see figure 1). This probability depends on the local tumor
density, and is given by
PL ¼
exp 2 uL
Tcnt
 2 
; Tcnt . 0
0; otherwise
8><
>: ð8Þ
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Here, Tcnt is the number of tumor cells in the 3 £ 3 square centered at the relevant grid
element, and uL determines the shape of the probability curve.
Additionally, CTLs can be recruited to the immediate neighborhood surrounding the
shared tumor-CTL grid site. The surrounding grid elements are sampled for further CTL
induction. For each neighboring element that does not currently contain a CTL, a new CTL
cell is created with probability PL. This specific lymphocyte recruitment facilitates the
satellitosis where T cells have been observed surrounding tumor cells undergoing apoptosis
[61]. For completeness we note that for a neighboring tumor cell count of zero, PL is defined
to be zero also.
In both cases, we note that CTL recruitment is possible as a result of either NK cells or
CTL cells coming into contact with tumor cells, and does not require tumor cell lysis, as do
the rules in [43].
When a tumor cell dies, in addition to updating the living and necrotic tumor populations,
we distinguish between whether the tumor cell was killed by CTLs or NKs, and deactivate
the immune cell, that is, reduce the immune cell count in that grid site accordingly.
If there is no cancer cell at a particular grid site, but there are immune cells, then the
immune cells may move. Unlike in [43], we allow NK cells to move about “semi-blindly”,
that is, they move preferentially toward an immune-cell-free grid location, regardless of
whether there is a tumor cell in that location or not. On the other hand, CTL cells move
preferentially toward a tumor-occupied location.
CTL and NK cell death. As in [43], CTLs are assumed to die by one of two means. Firstly,
they become functionally useless (and therefore, not tracked by the program) when their cell
kill value CTLkill is reduced to zero. (As in [43], it is assumed that the cells of the specific
immune system are able to lyse tumor cells more than once [38].) Secondly, the CTLs will
die off or—equivalently as far as the implementation is concerned—move away from the
domain of interest if they no longer detect tumor cells in their neighborhood. This cell
removal occurs with probability PLD (see figure 1):
PLD ¼
12 exp 2 uLD
Tcnt
 2 
; Tcnt . 0
0; otherwise
8><
>: ð9Þ
Here uLD is a parameter determining the steepness of the probability curve. The probability
of immune cell death is one when there are no tumor cells nearby.
NK cells, on the other hand, are removed in only one way: deactivation through NK–
tumor interactions. Currently, this occurs after an NK cell kills one tumor cell, since it is
assumed that, unlike CTLs, each NK cell has the ability to attack only one tumor cell and
then it is deactivated.
3. Simulations and results
In this section, we present simulations of various realizations of the model for different
parameter sets, in order to test the effect on morphology of changing consumption rates,
tumor gluttony, cell–cell adhesion and immune response. Two simulations with the same
parameters will give different outcomes because of the probabilistic nature of the model. The
simulations presented here are representative outcomes of typical simulation runs.
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3.1 Effects of nutrient consumption rates
Different rates of consumption of the mitotic nutrient have been considered previously by
Mallet and de Pillis [43] and by Ferreira et al. [26]. Increasing the uptake of the nutrient by
the tumor cells effectively increases their motility, since nutrient levels quickly become too
low to support cell life at sites with high tumor density. Figure 3 shows characteristic
growth patterns for different levels of nutrient consumption. On the left, the tumor
consumes mitotic nutrient at a slower rate and hence can grow in density without moving
far from the initial site of mutation. Note that this leads to the formation of a necrotic core
in the interior of the tumor where nutrient levels have fallen. On the right, the tumor cells
consume nutrient much faster than in the left hand simulation. To divide, the cells need to
move away from the initial site of the tumor, toward the regions of higher nutrient
concentration near the blood vessel, and a “fingered” growth develops. It is clear that
varying the rate of tumor-cell nutrient consumption can lead to quite different tumor
morphologies. It has been shown experimentally that a change in the tumor’s micro-
environment, in terms of pH or oxygenation, can affect a cell’s ability to metabolize
nutrient, [15]. Thus, manipulation of this micro-environment has been suggested as a
treatment strategy, [30].
3.2 Effects of tumor cell nutrient “Gluttony”
Tumor morphology is also affected by the ratio between consumption of nutrients by
tumor cells and the consumption by host and immune cells. For the two nutrients
respectively, the ratio is provided immediately by the parameters lN and lM. Figure 4
shows the spatial growth of a tumor with cells which consume both mitotic and survival
nutrients at a much greater rate (100 times as fast) than do the normal host cells. The
tumor evolves into a branched structure with cells actively searching for new areas with
high nutrient levels, leaving behind them necrotic debris caused by tumor cell death due to
a lack of nutrients. This is in contrast to the round-growth situation shown in the left side
Figure 3. Tumor growth after 450 iterations with white tumor cells and black necrotic cells, for nutrient
consumption rates lN: 1.5 (left) and 45 (right). lM ¼ 1.5, Nmin ¼ 0.83, Copt ¼ 2, udiv ¼ udel ¼ 0.08, uL ¼ 7, uN ¼ 1,
uLD ¼ 0.14, I0 ¼ 0.003, Is ¼ 0.25, CTLkill ¼ 1, NKkill ¼ 1, Mmin ¼ 0.725.
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of figure 3 where tumor cells consume nutrients at nearly the same rate, (1.5 times as fast),
as host cells.
Figure 5 shows that interestingly, a gluttonous approach to nutrient consumption is not
always advantageous for the tumor. In fact, considering the first 20–30 iterations shown in
the figure, the excessive consumption of nutrients could lead to quick tumor destruction. As
the tumor tries to establish itself, the depletion of local nutrient levels reduces the possibility
of cell division. Even if the tumor is able to establish high enough cell numbers to evade
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Figure 5. Number of tumor cells over time for two different gluttony levels—lM ¼ lN ¼ 1.5 (default, dotted line)
and lM ¼ lN ¼ 100 (high gluttony, solid line).
Figure 4. Tumor growth after 1000 iterations showing results of high tumor “gluttony” implemented through
parameter values lN ¼ lM ¼ 100. Other parameters are as given in figure 3.
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destruction completely, figure 4 shows that the cells are constantly in search of new nutrient-
rich areas of tissue which leads to the much lower, almost steady population of cells
illustrated by figure 5.
3.3 Effects of weak versus strong adhesion
Using the CA-adaptation of Turner’s work, we also examined the effects of cell adhesion on
the growth of tumors. Figure 6 shows the growth rates of tumors with three different values of
the Copt parameter. This parameter determines when a location in the CA holds the optimum
number of tumor cells and when the cells at that location would start spilling over into other
locations. It is shown that the growth rate is significantly increased for lower values of Copt,
and indeed for higher values of the parameter it appears quite possible that the tumor could
be destroyed given other favorable circumstances, since the population nears extinction
several times. The simulation suggests a possible mechanism for the initiation of metastasis
via an alteration of cell adhesiveness. Experimental evidence for such a mechanism and its
role in tumor growth is given in [35] and the references therein.
Figure 7 shows the spatial growth patterns of tumors with increasing tumor cell adhesion
parameters. Lower values of Copt, such as the zero value discussed earlier, force tumor cells
to move to other locations quickly, and take advantage of favorable nutrient conditions to
divide and increase the overall population. For higher Copt values, the tumor cells adhere to
each other, up to the optimal density, and are therefore more likely to remain in the location
of the parent cell. However, the growth of the tumor population is hindered by the fact that
the higher concentrations of cells consume more nutrients, and a necrotic core develops
inside a (more or less) convex viable tumor rim.
3.4 Effects of weak versus strong immune response
Mallet and de Pillis [43] discussed the effects of the immune system on the growth rate of
tumors and to a lesser extent the growth patterns. Here we see results regarding the effects of
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Figure 6. Tumor growth rate (number of tumor cells over time) as a function of the adhesion parameter,
Copt ¼ 0,2,5. Other parameters are as given in figure 3.
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different background immune system levels and CTL induction strengths on tumor growth.
In figure 8, a stronger natural immune system (I0 ¼ 0.003) is capable of controlling tumor
growth and rebound. The simulation shown on the right of this figure shows that if the tumor
can be detected by the immune system, it might decrease in size, but then can return to a
second growth phase evading the immune system’s control.
Figure 9 shows similar results to those found in [43] where a stronger recruitment of CTL
cells (uL ¼ 3) induces a faster and more effective immune response to the tumor. The weaker
response shown for uL ¼ 15 initially controls the tumor but the immune system is soon
overwhelmed and the tumor growth resumes. Note that while the CTL population does grow,
it does not happen quickly enough to control the tumor growth.
Figure 10 is the spatial description at 40 and 80 iterations of the same simulation shown in
figure 9. This shows the effect of the immune system, and in particular, the induction of CTL
cells to the site of the growth, on the morphology of the tumor. The immune cells appear to
surround then lyse the tumor cells for the case of strong induction. This is consistent with the
observations of [18] and [34] who note that in spontaneous regression/complete resistance
(SR/CR) mice, cancer cells induce infiltration of effector cells that form rosettes around the
cancer cells, followed by cancer cell destruction. For the weaker immune cell induction case,
some tumor cells are lysed, but most escape the immune attack, and continue to spread and
divide as described in previous sections.
Figure 7. Tumor growth patterns for various levels of adhesion. Left: Copt ¼ 0 and 250 iterations; center: Copt ¼ 2
and 1500 iterations; right: Copt ¼ 5 and 1000 iterations. Other parameters are as given in figure 3. Necrotic cells are
shown in black and living cells are shown in white.
Figure 8. Tumor growth after 700 iterations for two different underlying immune strengths: I0 ¼ 0.003 (left) and
I0 ¼ 0.001 (right), with uL ¼ 7. Living cells are shown in white and necrotic cells in black.
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Figure 9. Comparison of the cell populations (tumor, CTL, NK) over time for two different values of the CTL
induction parameter, uL ¼ 3 and 15. I0 ¼ 0.003 (default) in both cases.
Figure 10. Spatial view of the simulations described in figure 9 at 40 and 80 iterations. Living tumor cells are
shown in black and immune cells are shown in white.
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4. Discussion
The morphological development of a growing tumor can be significant when investigating
factors such as staging, potential for metastasis, immune cell infiltration, and treatment
effectiveness. The CA-hybrid model of tumor growth we have presented in this work
provides a set of rules that allow us to investigate spatio-temporal tumor growth in the
context of nutrient consumption rates, cell–cell adhesion and both innate and specific
immune responses. We have shown that each of these factors has some effect on the
morphology of the growing tumor, as well as on the tumor’s ability to establish itself.
In future versions of this model, we plan to incorporate further rules to reflect more details
of the biology at various scales. For example, we are currently working on the incorporation
of rules that drive cell-cycle dynamics and tumor invasion of normal tissue as a function of
realistic oxygen and glucose consumption rates, ATP production and waste excretion.
Additionally, for investigation of chemotherapy and immunotherapy treatments, we are
including vascular structures, and the effects of vascular growth and collapse.
Computational constraints are currently a major reason for running all the simulations
presented in this paper in two dimensions, instead of three. The computation of the diffusion
of the two chemical species consumes the majority of the simulation time. We tracked the
diffusion of nutrients by solving the steady state diffusion equation, a reasonable approach
since diffusion of the relevant chemicals takes place on a much shorter time scale than the
cell-cycle. This is an approach taken by others as well [26,27]. The significant time-sink in
the computational solution of the steady-state diffusion equations is the sparse matrix solver.
We tested multiple sparse matrix solvers, and found that the most efficient of the easy to
implement solvers was BiCGStab. We note, however, that all the sparse matrix solvers
encounter problems with break-down, and when that happens, another solver must be
employed, generally a direct solver. This approach is not the most computationally efficient,
but was the one used in [43]. We, therefore, implemented an alternate approach for the
simulations presented in this paper. With this alternate approach, diffusion is calculated using
discrete local rules, and concentrations are updated more often when changes in cell
populations occur. Numerical tests showed that this last approach was much faster, and
produced comparable results. Details of the numerical procedure will appear in a forthcoming
paper. We are currently considering the exploration of a multi-grid approach in hopes that this
will allow the extension of the current model to three space dimensions.
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